Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1260386 (
GSH
)
38,102
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The synthesis of glutathione in Escherichia coli K 12 was studied in crude, cell-free extracts. The pH optima and the apparent Km values for the substrates have been determined for both synthesizing enzymes,
gamma-glutamylcysteine synthetase
and glutathione synthetase. gamma-Glutamylcysteine synthetase was found to be approximately twice as active as glutathione synthetase. In a growing culture, the cellular level of
GSH
showed a considerable increase up to 6.6 mumol per ml cell pellet in the stationary growth phase. GSSG was not detectable. The levels of the enzymes remained constant, indicating that glutathione biosynthesis depends at least in the beginning on the availability of the component amino acids. The pathway is controlled by feedback inhibition and not by repression.
...
PMID:Glutathione biosynthesis in Escherichia coli K 12. Properties of the enzymes and regulation. 23 47
The thiol-oxidizing agent "diamide" (CH3)2NCON equal to NCON(CH3)2 was used to isolate mutants of Escherichia coli K 12 deficient in the biosynthesis of glutathione. A colony-colour technique has been developed for identification of colonies of these mutants. Four glutathione-deficient mutants were isolated. They show normal growth rates in minimal medium without
GSH
supplementation, indicating that glutathione is not involved in essential metabolic process. In one mutant, glutathione synthetase was entirely inactive. Three mutants were deficient in
gamma-glutamylcysteine synthetase
; in two of them, this resulted in a complete lack of
GSH
. These mutants were found to be more susceptible than their parent strains to a wide rang of chemical agents, but did not show a greater sensitivity to X-rays. It must be concluded that the protective role of glutathione is only significant when a chemical challenge is present.
...
PMID:Isolation and initial characterization of glutathione-deficient mutants of Escherichia coli K 12. 109 56
The kinetic effects of hydrogen peroxide (H2O2) on cultured endothelial cells isolated from bovine carotid artery were studied. The cytoprotective effects of glutathione (
GSH
) on H2O2-induced cell injury were also investigated. H2O2-induced a dose- and time-dependent cell injury in cultured endothelial cells. H2O2-induced cell injury was blocked by simultaneous treatment by catalase, but not by superoxide dismutase. H2O2 also induced endogenous PGI2 biosynthesis, and the maximum PGI2 production was reached after 1 h treatment. Stimulation of PGI2 production was parallel with arachidonate release from H2O2-treated cells. However the prostaglandin biosynthesis enzyme activity in cells was inhibited by H2O2 treatment. When the cells were treated with
GSH
, the intracellular
GSH
reached a plateau after 3 h treatment. Both H2O2-induced cell injury and PGI2 production were significantly inhibited by the 3 h pretreatment with
GSH
. The cytoprotective effect of
GSH
was completely inhibited by buthionine sulfoximine which is a specific inhibitor of
gamma-glutamylcysteine synthetase
. The results indicate that the cytoprotective effect of
GSH
on H2O2-induced cell injury in cultured bovine carotid artery endothelial cells depends on the increase in intracellular
GSH
content.
...
PMID:Cytoprotective effect of reduced glutathione in hydrogen peroxide-induced endothelial cell injury. 135 Dec 88
Glutathione (
GSH
), a major cellular antioxidant, is elevated 2- to 3-fold in kidneys of rats during prolonged treatment with mercury as methyl mercury hydroxide (MMH). Increased renal
GSH
is accompanied by a dose- and time-related elevation in the relative abundance of mRNA hybridizable to a cDNA probe which encodes renal
gamma-glutamylcysteine synthetase
(GCS), the rate-limiting enzyme in
GSH
synthesis. Renal GCS mRNA is maximally elevated 4.4-fold at 3 weeks following initiation of MMH treatment. Enhancement of
GSH
and GCS mRNA content corresponds to a relative sparing of renal cells from oxidative tissue damage during MMH exposure. These observations suggest that increased synthesis of
GSH
at the genetic level occurs as an initial adaptive response to mercury-induced oxidative stress in kidney cells.
...
PMID:Enhancement of gamma-glutamylcysteine synthetase mRNA in rat kidney by methyl mercury. 135 82
We reported that glucagon and phenylephrine decrease hepatocyte
GSH
by inhibiting
gamma-glutamylcysteine synthetase
(GCS), the rate-limiting enzyme in
GSH
synthesis (Lu, S.C., J. Kuhlenkamp, C. Garcia-Ruiz, and N. Kaplowitz. 1991. J. Clin. Invest. 88:260-269). In contrast, we have found that insulin (In, 1 microgram/ml) and hydrocortisone (HC, 50 nM) increased
GSH
of cultured hepatocytes up to 50-70% (earliest significant change at 6 h) with either methionine or cystine alone as the sole sulfur amino acid in the medium. The effect of In occurred independent of glucose concentration in the medium. Changes in steady-state cellular cysteine levels, cell volume,
GSH
efflux, or expression of gamma-glutamyl transpeptidase were excluded as possible mechanisms. Both hormones are known to induce cystine/glutamate transport, but this was excluded as the predominant mechanism since the induction in cystine uptake required a lag period of greater than 6 h, and the increase in cell
GSH
still occurred when cystine uptake was blocked. Assay of
GSH
synthesis in extracts of detergent-treated cells revealed that In and HC increased the activity of GCS by 45-65% (earliest significant change at 4 h) but not GSH synthetase. In and HC treatment increased the Vmax of GCS by 31-43% with no change in Km. Both the hormone-mediated increase in cell
GSH
and GCS activity were blocked with either cycloheximide or actinomycin D. Finally, when studied in vivo, streptozotocin-treated diabetic and adrenalectomized rats exhibited lower hepatic
GSH
levels and GCS activities than respective controls. Both of these abnormalities were prevented with hormone replacement. Thus, both in vitro and in vivo, In and glucocorticoids are required for normal expression of GCS.
...
PMID:Insulin and glucocorticoid dependence of hepatic gamma-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo. 135 65
The biochemical and molecular basis for the elevation of glutathione (
GSH
) levels commonly detected in many drug-resistant cells has not been elucidated. In a series of L-phenylalanine mustard-resistant human prostate carcinoma cell lines (DU-145), resistance was associated with elevated
GSH
levels, increased activity of
gamma-glutamylcysteine synthetase
(GCS), the rate-limiting enzyme in
GSH
biosynthesis, and a marked increase in the steady-state levels of GCS-specific transcripts (4.0 and 3.2 kilobases). Loss of the resistant phenotype was accompanied by a reduction in
GSH
and a return of GCS activity and transcript levels to values comparable to those detected in the drug-sensitive parent cells. These data strongly implicate up-regulation of GCS activity as an important mechanism in the evolution of drug resistance associated with increased levels of intracellular
GSH
. The results further suggest that the ability to synthesize
GSH
may be more indicative of resistance than steady-state
GSH
levels per se.
...
PMID:Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. 135 6
1. Six enzymes which collectively catalyze a number of glutathione-dependent synthetic, catabolic and detoxification reactions were examined along with glutathione status in liver, gills, and posterior kidney of channel catfish (Ictalurus punctatus). 2. Hepatic
GSH
concentrations were higher than those in kidney or gills. Oxidized glutathione (GSSG) concentrations were similar among the three tissues. 3. Specific (per unit protein)
gamma-glutamylcysteine synthetase
(GCS) activity was greater in the gills than in liver or posterior kidney. However, total organ GCS activity was greatest in the liver. 4. Specific and total hepatic glutathione peroxidase (GSH peroxidase) activities were substantially greater than those of gills or kidney. 5. Similar specific glutathione reductase (GSSG reductase) activities were observed among all three tissues. 6. All three tissues exhibited glutathione S-transferase (GST) activity towards 1-chloro-2,4-dinitrobenzene (CDNB). Specific and total organ GST activities were highest in the liver, followed by the posterior kidney and gills. 7. Gamma-glutamyltranspeptidase (GGT) activity was present in the posterior kidney, but was undetectable in the gills or liver.
...
PMID:A comparison of glutathione-dependent enzymes in liver, gills and posterior kidney of channel catfish (Ictalurus punctatus). 136 Mar 60
There is little known regarding the intracellular mechanisms of modification of damage in the ovary. Ovarian perfusion of en block dissections of the rat right ovary with aorta and vena cava were done to determine (a) if glutathione (
GSH
) is released by the ovary, (b) if the release is cycle dependent, and (c) if
GSH
released is the product of de novo ovarian synthesis. All perfused ovaries released
GSH
and the release was maximal at estrus and least at metestrus. Perfusion with buthionine sulfoximine, a specific inhibitor of
gamma-glutamylcysteine synthetase
, resulted in a dose-dependent reduction in
GSH
released, indicating inhibition of de novo synthesis during perfusion.
...
PMID:The effect of estrous cycle and buthionine sulfoximine on glutathione release from the in vitro perfused rat ovary. 136 1
Glutathione (
GSH
) and cysteine were determined in the plasma and the erythrocytes of alcoholic and non-alcoholic cirrhotics as fluorescent monobromobimane derivatives by high-performance liquid chromatography (HPLC). Cirrhotic patients displayed a significant decrease of plasma
GSH
, as well as of plasma cysteine, that was related to the degree of liver disease but not to the nutritional conditions. On the contrary, erythrocyte cysteine was found to increase significantly in all cirrhotics, particularly in alcoholics, regardless of the severity of disease. In an attempt to find a possible explanation of these alterations, the
GSH
synthesizing enzymes,
gamma-glutamylcysteine synthetase
(GC-s) and GSH synthetase (GSH-s) activities were determined in the erythrocytes.
GSH
-s activity was significantly lower in cirrhotic patients, whereas GC-s activity did not differ in the three groups.
...
PMID:Alteration of erythrocyte glutathione, cysteine and glutathione synthetase in alcoholic and non-alcoholic cirrhosis. 141 Dec 53
Since glutathione is thought to be involved in cerebral functions, changes in the glutathione level imply modulations of the neurotransmission in addition to all the known effects of
GSH
. It was investigated whether alterations of the cerebral glutathione can be induced by consumption of
GSH
, by inhibition or stimulation of the synthesis of
GSH
, or by an inhibition of the re-reduction of the oxidized glutathione. Aminophenazone, propyphenazone, acetaminophen, phenytoin, morphine and nitrofurantoin, known to deplete hepatic
GSH
, had no effects on cerebral
GSH
. Diethyl maleate (0.6 ml/kg) decreased the cerebral content of
GSH
and GSSG in adult rats as well as in fetuses. The depletion of the cerebral
GSH
caused by diethyl maleate treatment for 4 days was followed by an increase up to 125% and a subsequent return to the normal level after 1 week. In rats starved up to 71 h deficiency of exogenous amino acids caused only a minimal or no decrease in cerebral
GSH
. The specific inhibitor of the
gamma-glutamylcysteine synthetase
BSO only depleted
GSH
in the brain of young mice following the repeated s.c. administration of a high dose (890 mg/kg). After cobaltous chloride (20 mg/kg; twice a day for 2 or 4 days) the
GSH
level in the brain was unchanged. In vivo inhibition of the cerebral glutathione reductase was caused by ammonium metavanadate (12.5 mg/kg; three times a week for 6 weeks). Nitrofurantoin (150 mg/kg) had no effect. After lomustine (10 mg/kg) a minimal increase in glutathione reductase was found, but simultaneously also an increase in GSSG and of the ratio GSSG/total glutathione.
...
PMID:Effects of exogenous factors on the cerebral glutathione in rodents. 151 27
1
2
3
4
5
6
7
8
9
10
Next >>